EGRIFTA WR
- Product NDC
- 62064-381
- 11-digit product format
- 620640381
- Labeler code
- 62064
- Product ID
- 62064-381_deec4b7a-7e9a-4a13-bb05-8a392c4b3937
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tesamorelin
- Dosage form
- KIT
- Route
- SUBCUTANEOUS
- Labeler
- Theratechnologies Inc.
- Application
- BLA022505
- Marketing category
- BLA
- Marketing start
- 2025-07-15
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- EGRIFTA WR
- Listing expiration
- 2026-12-31
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Rxcui | 2719314, 2719316 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62064-381-04 | EGRIFTA WR | 1 in 1 BOX | KIT | 1 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62064-381-04 | 62064038104 | 1 KIT in 1 BOX (62064-381-04) * 1.3 mL in 1 VIAL (62064-371-01) * 30 mL in 1 BOTTLE | 1 kit | 2025-07-15 | No | No | Historical |